Global coverage of infant Haemophilus influenzae type b (Hib) vaccination has increased
considerably during the past decade, partly due to GAVI Alliance donations of the vaccine to …

Background: Conjugate vaccines against Haemophilus influenzae type b (Hib) are widely
used. The full implications of Hib vaccination schedule for vaccine effectiveness (VE) are …

Background: The optimal schedule and the need for a booster dose are unclear for
Haemophilus influenzae type b (Hib) conjugate vaccines. We systematically reviewed …

Prior to widespread vaccination, Haemophilus influenzae type b was a leading cause of
severe childhood bacterial infection, including meningitis, worldwide. Over the last decade …

Haemophilus influenzae type b (Hib) is an important cause of meningitis and pneumonia in
children. Despite the availability of Hib conjugate vaccine, many countries are still to …

Prior to the introduction of vaccines, Haemophilus influenzae type b (Hib) was the most
common cause of bacterial meningitis and an important cause of severe pneumonia in …

Objective Our objective was to review data from observational studies and surveillance
reports on Hib vaccine effectiveness. This review specifically seeks to assess which of the …

The use of the highly effective Haemophilus influenzae type b (Hib) conjugate vaccine has
increased globally. We review the benefits and limitations of studies measuring Hib vaccine …

Haemophilus influenzae type b (Hib) infection is a leading cause of meningitis and
pneumonia in infants and children in developing countries, and yet the implementation of …

Haemophilus influenzae (Hi) is responsible for significant morbidity and mortality worldwide,
particularly in children under 5 years of age. In the pre-vaccine era, 95% of serious disease …